Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 25, 2024
Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) announced the expansion of Ichor Clinical’s services to Australia, Europe, and the United Kingdom.
read more
Tuesday, September 21, 2021
Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences’ emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette...
read more
ICIG announced today changes in the management of CordenPharma, its pharmaceutical contract manufacturing business.
read more
ICON has acquired a majority shareholding in MeDiNova Research, a site network with research sites in key markets in Europe and Africa.
read more
ICON announced that it has acquired the Mapi Group.
read more
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ...
read more
Thursday, October 24, 2019
ICON has acquired Symphony Clinical Research, a provider of at-home patient and site support services.
read more
ICON plc announced the completion of its acquisition of PRA Health Sciences. The combined company will retain the name ICON and will bring together 38,000 employees across 47 countries, creating the world’s most advanced healthcare intelligence and ...
read more
ICON announced the appointment of Julie O’Neill as a non-executive director.
read more
ICON announced it is working with Practice Fusion to leverage active patient data in support of health research.
read more
ICON plc, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has announced that, as part of its planned succession of executive leadership, Mr. Ciaran Murray will ...
read more
Baxter announced the FDA clearance of the Spectrum IQ Infusion System with Dose IQ Safety Software.
read more
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer Inc.
read more
Thursday, November 11, 2021
ICON plc announces that its Accellacare Site Network has expanded in reach and capabilities through new partnerships with six research sites across four countries.
read more
Tuesday, January 28, 2014
a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Dr. Dariush Elahi as Director of Metabolic Research. Based in ICON’s Clinical Pharmacology ...
read more